open
Homepage

Our initiatives

Supporting patients through partnership: a collaborative approach to developing better medicines and enhancing patient journeys.

Our initiatives

At J&J, we believe in partnering with patients and caregivers. By seeing patients as our partners, we can understand how to better meet their needs and improve the patient’s health care journey. Patient engagement means collaborating and integrating the voice of the patient so we can improve all stages of a patients’ journey - from the time they begin having symptoms, until after recovery. Early, systematic, and frequent contact with patients has far-reaching advantages and we understand that engaged patients are better able to make informed decisions about their care.

It’s time to Talk Lung Cancer

Talk Lung Cancer has been developed with input from the lung cancer community to provide you with useful resources to support your journey and have informed conversations about your care.

References

[1]
NHS. Amyloidosis. Accessed May 26, 2022.
[2]
McCausland KL, White MK, Guthrie SD, et al. Light chain (AL) amyloidosis: the journey to diagnosis. The Patient-Patient-Centered Outcomes Research. 2018;11(2):207-16.
[3]
Cancer.Net. Amyloidosis: Symptoms and Signs. Accessed May 26, 2022.
[4]
Mayo Clinic. Amyloidosis overview: symptoms and causes. Accessed May 26, 2022.
[5]
National Organization for Rare Disorders. Amyloidosis. Accessed May 26, 2022.
[6]
D'Errico S, Mazzanti A, Baldari B, Maiese A, Frati P, Fineschi V. Sudden death in lambda light chain AL cardiac amyloidosis: a review of literature and update for clinicians and pathologists. Int J Clin Exp Pathol. 2020 Jul 1;13(7):1474-1482. PMID: 32782665; PMCID: PMC7414507.
[7]
Mayo Clinic. Amyloidosis diagnosis and treatment. Accessed August 20, 2020.
[8]
Lousada I, Comenzo RL, Landau H, et al. Light chain amyloidosis: patient experience survey from the Amyloidosis Research Consortium. Advances in Therapy. 2015;32(10):920-928.
[9]
Merlini G, Dispenzieri A, Sanchorawala V, et al. Systematic immunglobulin light chain amyloidosis. Nature Review Disease Primers. 2018;4(1):38.
[10]
Hasib Sidiqi M, Gertz MA. Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021. Blood cancer journal. 2021;11(5):1-9.